Results 41 to 50 of about 4,656 (255)

Métodos para a avaliação da hiperalgesia induzida por opioides no período perioperatório [PDF]

open access: yes, 2014
BACKGROUND AND OBJECTIVES: Opioid-induced hyperalgesia is a topic not yet fully understood in terms of mechanisms, diagnosis, prevention and treatment. Thus, it seems of great importance to evaluate this phenomenon that negatively affects the treatment ...
Leal, Plínio da Cunha   +1 more
core   +1 more source

Comparing Early Postoperative Period Analgesic Effect of Dexketoprofene Trometamol and Lornoxicam in Mediastinoscopy Cases

open access: yesEurasian Journal of Medicine, 2019
Objective: In this study, we aimed comparing early postoperative period analgesic effectiveness and the effects on opioid consumption of intravenous dexketoprofen and lornoxicam that are given preemptively.
Gonul Sagiroglu
doaj   +1 more source

Intraarticular levobupivacaine lornoxicam and morphine analgesia after knee arthroscopy: a randomized controlled trial

open access: yesActa Orthopaedica et Traumatologica Turcica, 2020
Objective: The aim of this study was to compare the analgesic effects of intra-articular levobupivacaine alone, intra-articular levobupivacaine in combination with lornoxicam, and intra-articular levobupivacaine in combination with lornoxicam and ...
Onder Ersan   +3 more
doaj   +1 more source

Pharmacokinetic profiles of the active metamizole metabolites in healthy horses [PDF]

open access: yes, 2016
Metamizole (MT) is an analgesic and antipyretic drug labelled for use in humans, horses, cattle, swine and dogs. MT is rapidly hydrolysed to the active primary metabolite 4-methylaminoantipyrine (MAA).
. LEE, Hk   +7 more
core   +1 more source

Brief Effect of a Small Hydrophobic Drug (Cinnarizine) on the Physicochemical Characterisation of Niosomes Produced by Thin-Film Hydration and Microfluidic Methods [PDF]

open access: yes, 2018
first_pagesettings Open AccessArticle Brief Effect of a Small Hydrophobic Drug (Cinnarizine) on the Physicochemical Characterisation of Niosomes Produced by Thin-Film Hydration and Microfluidic Methods by Li Key YeoOrcID,Temidayo O. B.
Chaw, Cheng   +3 more
core   +1 more source

Improved solubility of lornoxicam by inclusion into SBA-15: comparison of loading methods.

open access: yesEuropean Journal of Pharmaceutical Sciences, 2022
An increasing proportion of new medicinal substances are poorly soluble in water. Adsorption on mesoporous silicas increases their bioavailability when administered orally.
Adrianna Dadej   +8 more
semanticscholar   +1 more source

Effects of Omega-3 Co-Administered with Therapeutic Dose of lornoxicam on Male Rats' Liver

open access: yesIraqi Journal of Pharmaceutical Sciences, 2019
The purpose of this study was to investigate the effect of omega-3 poly unsaturated fatty-acids co-administered with the therapeutic dose of lornoxicam on liver of healthy rats.
Israa A. Majeed, Nada N. Al-Shawi
doaj   +1 more source

Mutations in pre-core and basal-core promoter regions of hepatitis B virus in chronic HBV patients from Golestan, Iran [PDF]

open access: yes, 2014
Objective(s): It has been reported that the mutation of the pre-core (PC) and basal-core promoter (BCP) may play an important role in the development of HBV-related hepatocellular carcinoma (HCC).
Bazouri, M.   +5 more
core   +2 more sources

Dissolution Enhancement and Formulation of Rapid-Release Lornoxicam Mini-Tablets [PDF]

open access: yes
The aim was to enhance the dissolution of lornoxicam (LOR) and to produce mini-tablets with an optimised system to provide a rapid-release multi-particulate formulation.
Abou-Taleb   +66 more
core   +1 more source

Antipyretic therapy in critically ill septic patients: A systematic review and meta-analysis [PDF]

open access: yes, 2017
OBJECTIVE: This meta-analysis aimed to examine the impact of antipyretic therapy on mortality in critically ill septic adults. DATA SOURCES: Literature searches were implemented in Ovid Medline, Embase, Scopus, Cumulative Index of Nursing and Allied ...
Bernard   +44 more
core   +2 more sources

Home - About - Disclaimer - Privacy